Participant and interventionist perceptions of challenges during behavioral weight loss treatment.

Journal of Behavioral Medicine
Christine C CallM L Butryn

Abstract

No prior studies have examined how interventionists' perceptions of participants' weight control challenges or the agreement between participants and interventionists on these perceptions relate to outcomes during group-based behavioral weight loss treatment. This study characterized participants' and interventionists' perceptions of, and agreement about, weight control challenges and assessed how these factors relate to weight loss. Three months into treatment, participants and interventionists independently selected three weight control challenges believed to be most relevant for each participant. Weight was measured at baseline, 3 months, and 12 months. Interventionists and participants had "no" (κ < 0) or "slight" (0 < κ< .20) agreement on most challenges. Although endorsement of certain challenges by participants and/or interventionists was related to 3- and 12-month weight losses, agreement between participants and interventionists was unrelated to weight loss at either time point. Additional research is needed to better understand the role of perceived challenges and participant/interventionist agreement about challenges on treatment outcomes.

References

Feb 15, 2001·Archives of Internal Medicine·T A WaddenC Steinberg
Nov 28, 2002·Diabetes Care·UNKNOWN Diabetes Prevention Program (DPP) Research Group
Oct 16, 2004·Obesity Research·Rena R WingUNKNOWN Diabetes Prevention Program Research Group
Jan 19, 2005·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P J TeixeiraT G Lohman
Jul 21, 2006·Obesity·UNKNOWN Look AHEAD Research GroupShiriki Kumanyika
Oct 13, 2006·The New England Journal of Medicine·Rena R WingJoseph L Fava
Aug 25, 2007·Annual Review of Clinical Psychology·Howard N Garb
Dec 7, 2007·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C A BefortJ E Donnelly
Jan 31, 2009·Obesity·Thomas A WaddenUNKNOWN Look AHEAD Research Group
Oct 14, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J G ChristianD H Bessesen
Dec 28, 2010·Journal of the American Dietetic Association·Lora E BurkeMary Ann Sevick
Jun 15, 2011·Journal of Nutrition Education and Behavior·Ericka M WelshPatricia S Laqua
Mar 1, 2004·Psychotherapy Research : Journal of the Society for Psychotherapy Research·Michael A Busseri, John D Tyler
Nov 22, 2011·The Psychiatric Clinics of North America·Meghan L ButrynThomas A Wadden
Mar 1, 2012·American Journal of Health Behavior·Melanie Warziski TurkLora E Burke
Nov 6, 2013·JAMA : the Journal of the American Medical Association·Alison E FieldShuji Ogino
Feb 14, 2014·The International Journal of Behavioral Nutrition and Physical Activity·Elizabeth M VendittiUNKNOWN Diabetes Prevention Program Research Group
Jan 31, 2015·The New England Journal of Medicine·Francis S Collins, Harold Varmus
Jul 15, 2015·Journal of Nutrition Education and Behavior·Jing WangLora E Burke
Oct 21, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·A E MuntM Allman-Farinelli
Oct 28, 2016·Journal of Consulting and Clinical Psychology·Eran Bar-KalifaWolfgang Lutz

❮ Previous
Next ❯

Citations

Mar 5, 2020·Obesity Science & Practice·Christine C CallMeghan L Butryn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.